NDC 17772-121

OXTELLAR XR

Oxcarbazepine

OXTELLAR XR is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Supernus Pharmaceuticals, Inc.. The primary component is Oxcarbazepine.

Product ID17772-121_7f8141e7-d103-70d9-e053-2991aa0a094e
NDC17772-121
Product TypeHuman Prescription Drug
Proprietary NameOXTELLAR XR
Generic NameOxcarbazepine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-01-17
Marketing CategoryNDA / NDA
Application NumberNDA202810
Labeler NameSupernus Pharmaceuticals, Inc.
Substance NameOXCARBAZEPINE
Active Ingredient Strength150 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 17772-121-01

100 TABLET in 1 BOTTLE (17772-121-01)
Marketing Start Date2013-01-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17772-121-01 [17772012101]

OXTELLAR XR TABLET
Marketing CategoryNDA
Application NumberNDA202810
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-01-17

NDC 17772-121-10 [17772012110]

OXTELLAR XR TABLET
Marketing CategoryNDA
Application NumberNDA202810
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-17

Drug Details

Active Ingredients

IngredientStrength
OXCARBAZEPINE150 mg/1

OpenFDA Data

SPL SET ID:aa610e56-1d1d-11e1-8bc2-0800200c9a66
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1365653
  • 1365850
  • 1365847
  • 1365660
  • 1365842
  • 1365844
  • UPC Code
  • 0317772121018
  • 0317772122015
  • 0317772123012
  • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    Medicade Reported Pricing

    17772012101 OXTELLAR XR 150 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "OXTELLAR XR" or generic name "Oxcarbazepine"

    NDCBrand NameGeneric Name
    17772-122OXTELLAR XROXTELLAR XR
    17772-121OXTELLAR XROXTELLAR XR
    17772-123OXTELLAR XROXTELLAR XR
    0054-0097OxcarbazepineOxcarbazepine
    0054-0098OxcarbazepineOxcarbazepine
    0054-0099OxcarbazepineOxcarbazepine
    0054-0199OxcarbazepineOxcarbazepine
    0615-6593OxcarbazepineOxcarbazepine
    0615-6594OxcarbazepineOxcarbazepine
    0615-6595OxcarbazepineOxcarbazepine
    0615-8153OxcarbazepineOxcarbazepine
    0078-0337Trileptaloxcarbazepine
    0078-0357Trileptaloxcarbazepine
    0078-0456Trileptaloxcarbazepine
    0078-0457Trileptaloxcarbazepine

    Trademark Results [OXTELLAR XR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    OXTELLAR XR
    OXTELLAR XR
    85732114 4441262 Live/Registered
    Supernus Pharmaceuticals, Inc.
    2012-09-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.